Library

2-MPPP

2-MPPP (2-methyl-1-phenyl-3-(piperidin-1-yl)propan-1-one) is a little-studied research chemical first reported in 2014-2015. No formal toxicology or pharmacokinetic data exist. Users describe short-lived, 'clean' mental stimulation with mild euphoria, minimal peripheral push, and a relatively soft comedown. Neurotoxicity, cardiotoxicity, and long-term health effects are unknown; treat with the same caution as any novel cathinone-like stimulant. Use accurate scales (±1 mg), start low, stay hydrated, avoid redosing more than once per 4-6 hours, and monitor blood pressure and heart rate.

Also known as: N-piperidinecathinone

Classification

  • Chemical: Cathinone
  • Psychoactive: Stimulant
  • Tag: Habit-Forming
  • Tag: Β-keto phenylpiperidine
  • Tag: Research-Chemical
  • Tag: Tentative

Effects

  • Mental Stimulationalertness
  • Bruxism And Jaw Tension
  • Mild Vasoconstriction
  • Sweating
  • Tachycardia And Elevated Blood Pressure
  • Insomnia
  • Euphoria
  • Mood Elevation
  • Increased Sociability And Talkativeness
  • Motivation Enhancement
  • Anxiety Or Irritability On Comedown
  • Increased Sociability
  • Music Appreciation Enhancement
  • Appetite Suppression
  • Increased Sexuality
  • Visual And Auditory Hallucinations
  • Increased Music Appreciation
  • Open Eye Visuals

Routes of Administration

Oral

Dosage

  • Threshold: 15 mg
  • Light: 25-50 mg
  • Common: 50-100 mg
  • Strong: 100-150 mg
  • Heavy: 150 mg +

Duration

  • Onset: 0.33-0.5 h
  • Peak: 0.5-1.5 h
  • Offset: 1-2 h
  • After Effects: 1-12 h

Insufflated

Dosage

  • Threshold: 10 mg
  • Light: 15-30 mg
  • Common: 30-60 mg
  • Strong: 60-110 mg
  • Heavy: 110 mg +

Duration

  • Onset: 0.05-0.12 h
  • Peak: 0.5-1.5 h
  • Offset: 1-2 h
  • After Effects: 1-12 h

Rectal

Dosage

  • Threshold: 10 mg
  • Light: 20-40 mg
  • Common: 40-80 mg
  • Strong: 80-120 mg
  • Heavy: 120 mg +

Duration

  • Onset: 0.03-0.08 h
  • Peak: 0.5-1.5 h
  • Offset: 1-2 h
  • After Effects: 1-12 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

2-MPPP - DrugsPRO ръководство за вещества

2-MPPP: 2-MPPP (2-methyl-1-phenyl-3-(piperidin-1-yl)propan-1-one) is a little-studied research chemical first reported in 2014-2015. No formal toxicology or pharmacokinetic data exist. Users describe short-lived, 'clean' mental stimulation with mild euphoria, minimal peripheral push, and a relativel

Related pages